This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Medtronic, Covidien further extend timing agreement with the FTC

( November 21, 2014, 14:49 GMT | Official Statement) -- MLex Summary: Medical device companies Medtronic and Covidien said that in order to further their cooperation with the US Federal Trade Commission they have agreed to not close their transaction prior to Dec. 7, according to a Covidien regulatory filing on Friday. The deal received a request for additional information from the FTC on Aug. 6.Extract....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login